comparemela.com

Latest Breaking News On - Precisedx - Page 1 : comparemela.com

UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence

/PRNewswire/ PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease.

Los angelesUnited statesHannah davisNicholas stanzioneMichaelj donovanClinical laboratory improvement amendmentsHealth systemDepartment of pathologyClinical laboratory evaluation programLaboratory medicine in los angelesLaboratory medicineYork state department of healthArtificial intelligencePrecisebreast mount sinai hospitalAssistant clinical professorChief medical officer

PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting

/PRNewswire/ PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced that it will present a poster showcasing the.

United statesNew orleansMichael donovanAlyson kuritzCanadian academy of pathologyCanadian academyAnnual meetingChief medicalPrecisedx platformPhenotyping platformPredict riskEarly stage breast cancer recurrenceMorphology feature array

PreciseDx Appoints Bradley Gendell as Chief Financial Officer

/PRNewswire/ PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced the appointment of Bradley Gendell as Chief.

United statesWayne brinsterWarburg pincusAlyson kuritzHarvard business schoolMorgan stanleyMasters in business administrationWilliams collegeBradley gendellChief financialManaging directorEnabled breast diagnosticVice presidentAcclivity capital managementManaging principalBusiness administration

PreciseDx Appoints Paul Roma as Chairman of the Board

/PRNewswire/ PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced the appointment of Paul Roma as Chairman of.

Wayne brinsterMolly harperSloan ketteringAlyson kuritzBroad instituteWatson healthCiox healthMount sinai health systemSynlogic incPaul romaPrecisedx breast testMemorial sloan ketteringMayo clinicSenior advisorFrancisco partnersGeneral manager

PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard

/PRNewswire/ PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced its recent publication in Breast Cancer.

Michael donovanWayne brinsterAlyson kuritzBreast cancer researchCancer researchEnabled digital breast cancer assayMorphology feature arrayMount sinai hospitalPrecisedx platformChief medical officer

vimarsana © 2020. All Rights Reserved.